The subject of the present invention is a novel pharmaceutical compositioncontainingamorphous rosuvastatin calcium, and magnesium hydroxide and/or calcium acetateor calciumgluconate or calcium glycerophosphate or aluminum hydroxide as stabilizingadditive and oneor more pharmaceutically acceptable excipients.